Report Thumbnail
Product Code LP0912312527XC
Published Date 2026/3/5
English123 PagesGlobal

Global Cerebral Aneurysm Coil Market Growth 2026-2032 ‐ MedicalDevice / MedTech Market


Report Thumbnail
Product Code LP0912312527XC◆An updated version may be available. We will check for you.
Published Date 2026/3/5
English 123 PagesGlobal

Global Cerebral Aneurysm Coil Market Growth 2026-2032 ‐ MedicalDevice / MedTech Market



Abstract

This report provides a comprehensive analysis of the global cerebral aneurysm coil market, projecting significant growth from 2025 through 2032. It examines critical medical devices used to treat life-threatening brain aneurysms, segmenting the industry by type, such as pushable and detachable coils, and application across hospitals and clinics. Covering key regions including the Americas, APAC, and Europe, the study highlights competitive strategies of major players like Medtronic and Johnson & Johnson while identifying emerging market opportunities and technological trends.

Related Questions

US$ 1477 million in 2025; US$ 2842 million in 2032

10.0% (2026 to 2032)

Johnson & Johnson, Medtronic, Boston Scientific, Stryker, Terumo Neuro, Penumbra, Kaneka, NeuroSafe, Zylox Tonbridge, Cook Medical, Peijia Medical, MicroPort


Summary

Market Overview

Global Market Forecast

The global Cerebral Aneurysm Coil market size is predicted to grow from US$ 1477 million in 2025 to US$ 2842 million in 2032; it is expected to grow at a CAGR of 10.0% from 2026 to 2032.

Regional Market Forecasts

  • United States: The market for Cerebral Aneurysm Coil is estimated to experience growth from 2025 through 2032.
  • China: The market for Cerebral Aneurysm Coil is estimated to experience growth from 2025 through 2032.
  • Europe: The market for Cerebral Aneurysm Coil is estimated to experience growth from 2025 through 2032.

Product Definition

A cerebral aneurysm coil is a medical device used in the treatment of cerebral aneurysms. Cerebral aneurysms are balloon-like bulges in the walls of blood vessels in the brain that can rupture, leading to life-threatening conditions such as subarachnoid hemorrhage (SAH).

Market Segmentation

By Type

  • Pushable Coil
  • Detachable Coil

By Application

  • Hospital
  • Clinic

By Geography

  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

Competitive Landscape

Key Market Dynamics

Global key Cerebral Aneurysm Coil players include Johnson & Johnson, Medtronic, Boston Scientific, Stryker, and Terumo Neuro. In terms of revenue, the global two largest companies occupied a significant market share in 2025.

Profiled Companies

The following companies have been profiled based on inputs gathered from primary experts and an analysis of the company's coverage, product portfolio, and market penetration:

  • Johnson & Johnson
  • Medtronic
  • Boston Scientific
  • Stryker
  • Terumo Neuro
  • Penumbra
  • Kaneka
  • NeuroSafe
  • Zylox Tonbridge
  • Cook Medical
  • Peijia Medical
  • MicroPort

Report Scope and Methodology

Research Overview

LP Information, Inc. (LPI)'s newest research report, the “Cerebral Aneurysm Coil Industry Forecast,” looks at past sales and reviews total world Cerebral Aneurysm Coil sales in 2025, providing a comprehensive analysis by region and market sector of projected Cerebral Aneurysm Coil sales for 2026 through 2032. With Cerebral Aneurysm Coil sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cerebral Aneurysm Coil industry.

Analytical Depth

This Insight Report provides a comprehensive analysis of the global Cerebral Aneurysm Coil landscape and highlights key trends related to:

  • Product segmentation
  • Company formation
  • Revenue and market share
  • Latest developments
  • M&A activity

Furthermore, the report analyzes the strategies of leading global companies with a focus on Cerebral Aneurysm Coil portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cerebral Aneurysm Coil market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cerebral Aneurysm Coil and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cerebral Aneurysm Coil. This report presents a comprehensive overview, market shares, and growth opportunities of Cerebral Aneurysm Coil market by product type, application, key manufacturers and key regions and countries.

Key Questions Addressed

  • What is the 10-year outlook for the global Cerebral Aneurysm Coil market?
  • What factors are driving Cerebral Aneurysm Coil market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Cerebral Aneurysm Coil market opportunities vary by end market size?
  • How does Cerebral Aneurysm Coil break out by Type, by Application?

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Cerebral Aneurysm Coil Annual Sales 2021-2032
      • 2.1.2 World Current & Future Analysis for Cerebral Aneurysm Coil by Geographic Region, 2021, 2025 & 2032
      • 2.1.3 World Current & Future Analysis for Cerebral Aneurysm Coil by Country/Region, 2021, 2025 & 2032
    • 2.2 Cerebral Aneurysm Coil Segment by Type
      • 2.2.1 Pushable Coil
      • 2.2.2 Detachable Coil
      • 2.2.3 Cerebral Aneurysm Coil Sales by Type
        • 2.2.3.1 Global Cerebral Aneurysm Coil Sales Market Share by Type (2021-2026)
        • 2.2.3.2 Global Cerebral Aneurysm Coil Revenue and Market Share by Type (2021-2026)
        • 2.2.3.3 Global Cerebral Aneurysm Coil Sale Price by Type (2021-2026)
    • 2.3 Cerebral Aneurysm Coil Segment by Application
      • 2.3.1 Hospital
      • 2.3.2 Clinic
      • 2.3.3 Cerebral Aneurysm Coil Sales by Application
        • 2.3.3.1 Global Cerebral Aneurysm Coil Sale Market Share by Application (2021-2026)
        • 2.3.3.2 Global Cerebral Aneurysm Coil Revenue and Market Share by Application (2021-2026)
        • 2.3.3.3 Global Cerebral Aneurysm Coil Sale Price by Application (2021-2026)
  • 3 Global by Company

    • 3.1 Global Cerebral Aneurysm Coil Breakdown Data by Company
      • 3.1.1 Global Cerebral Aneurysm Coil Annual Sales by Company (2021-2026)
      • 3.1.2 Global Cerebral Aneurysm Coil Sales Market Share by Company (2021-2026)
    • 3.2 Global Cerebral Aneurysm Coil Annual Revenue by Company (2021-2026)
      • 3.2.1 Global Cerebral Aneurysm Coil Revenue by Company (2021-2026)
      • 3.2.2 Global Cerebral Aneurysm Coil Revenue Market Share by Company (2021-2026)
    • 3.3 Global Cerebral Aneurysm Coil Sale Price by Company
    • 3.4 Key Manufacturers Cerebral Aneurysm Coil Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers Cerebral Aneurysm Coil Product Location Distribution
      • 3.4.2 Players Cerebral Aneurysm Coil Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
    • 3.6 New Products and Potential Entrants
    • 3.7 Market M&A Activity & Strategy
  • 4 World Historic Review for Cerebral Aneurysm Coil by Geographic Region

    • 4.1 World Historic Cerebral Aneurysm Coil Market Size by Geographic Region (2021-2026)
      • 4.1.1 Global Cerebral Aneurysm Coil Annual Sales by Geographic Region (2021-2026)
      • 4.1.2 Global Cerebral Aneurysm Coil Annual Revenue by Geographic Region (2021-2026)
    • 4.2 World Historic Cerebral Aneurysm Coil Market Size by Country/Region (2021-2026)
      • 4.2.1 Global Cerebral Aneurysm Coil Annual Sales by Country/Region (2021-2026)
      • 4.2.2 Global Cerebral Aneurysm Coil Annual Revenue by Country/Region (2021-2026)
    • 4.3 Americas Cerebral Aneurysm Coil Sales Growth
    • 4.4 APAC Cerebral Aneurysm Coil Sales Growth
    • 4.5 Europe Cerebral Aneurysm Coil Sales Growth
    • 4.6 Middle East & Africa Cerebral Aneurysm Coil Sales Growth
  • 5 Americas

    • 5.1 Americas Cerebral Aneurysm Coil Sales by Country
      • 5.1.1 Americas Cerebral Aneurysm Coil Sales by Country (2021-2026)
      • 5.1.2 Americas Cerebral Aneurysm Coil Revenue by Country (2021-2026)
    • 5.2 Americas Cerebral Aneurysm Coil Sales by Type (2021-2026)
    • 5.3 Americas Cerebral Aneurysm Coil Sales by Application (2021-2026)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Cerebral Aneurysm Coil Sales by Region
      • 6.1.1 APAC Cerebral Aneurysm Coil Sales by Region (2021-2026)
      • 6.1.2 APAC Cerebral Aneurysm Coil Revenue by Region (2021-2026)
    • 6.2 APAC Cerebral Aneurysm Coil Sales by Type (2021-2026)
    • 6.3 APAC Cerebral Aneurysm Coil Sales by Application (2021-2026)
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan
  • 7 Europe

    • 7.1 Europe Cerebral Aneurysm Coil by Country
      • 7.1.1 Europe Cerebral Aneurysm Coil Sales by Country (2021-2026)
      • 7.1.2 Europe Cerebral Aneurysm Coil Revenue by Country (2021-2026)
    • 7.2 Europe Cerebral Aneurysm Coil Sales by Type (2021-2026)
    • 7.3 Europe Cerebral Aneurysm Coil Sales by Application (2021-2026)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Cerebral Aneurysm Coil by Country
      • 8.1.1 Middle East & Africa Cerebral Aneurysm Coil Sales by Country (2021-2026)
      • 8.1.2 Middle East & Africa Cerebral Aneurysm Coil Revenue by Country (2021-2026)
    • 8.2 Middle East & Africa Cerebral Aneurysm Coil Sales by Type (2021-2026)
    • 8.3 Middle East & Africa Cerebral Aneurysm Coil Sales by Application (2021-2026)
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of Cerebral Aneurysm Coil
    • 10.3 Manufacturing Process Analysis of Cerebral Aneurysm Coil
    • 10.4 Industry Chain Structure of Cerebral Aneurysm Coil
  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 Cerebral Aneurysm Coil Distributors
    • 11.3 Cerebral Aneurysm Coil Customer
  • 12 World Forecast Review for Cerebral Aneurysm Coil by Geographic Region

    • 12.1 Global Cerebral Aneurysm Coil Market Size Forecast by Region
      • 12.1.1 Global Cerebral Aneurysm Coil Forecast by Region (2027-2032)
      • 12.1.2 Global Cerebral Aneurysm Coil Annual Revenue Forecast by Region (2027-2032)
    • 12.2 Americas Forecast by Country (2027-2032)
    • 12.3 APAC Forecast by Region (2027-2032)
    • 12.4 Europe Forecast by Country (2027-2032)
    • 12.5 Middle East & Africa Forecast by Country (2027-2032)
    • 12.6 Global Cerebral Aneurysm Coil Forecast by Type (2027-2032)
    • 12.7 Global Cerebral Aneurysm Coil Forecast by Application (2027-2032)
  • 13 Key Players Analysis

    • 13.1 Johnson & Johnson
      • 13.1.1 Johnson & Johnson Company Information
      • 13.1.2 Johnson & Johnson Cerebral Aneurysm Coil Product Portfolios and Specifications
      • 13.1.3 Johnson & Johnson Cerebral Aneurysm Coil Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.1.4 Johnson & Johnson Main Business Overview
      • 13.1.5 Johnson & Johnson Latest Developments
    • 13.2 Medtronic
      • 13.2.1 Medtronic Company Information
      • 13.2.2 Medtronic Cerebral Aneurysm Coil Product Portfolios and Specifications
      • 13.2.3 Medtronic Cerebral Aneurysm Coil Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.2.4 Medtronic Main Business Overview
      • 13.2.5 Medtronic Latest Developments
    • 13.3 Boston Scientific
      • 13.3.1 Boston Scientific Company Information
      • 13.3.2 Boston Scientific Cerebral Aneurysm Coil Product Portfolios and Specifications
      • 13.3.3 Boston Scientific Cerebral Aneurysm Coil Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.3.4 Boston Scientific Main Business Overview
      • 13.3.5 Boston Scientific Latest Developments
    • 13.4 Stryker
      • 13.4.1 Stryker Company Information
      • 13.4.2 Stryker Cerebral Aneurysm Coil Product Portfolios and Specifications
      • 13.4.3 Stryker Cerebral Aneurysm Coil Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.4.4 Stryker Main Business Overview
      • 13.4.5 Stryker Latest Developments
    • 13.5 Terumo Neuro
      • 13.5.1 Terumo Neuro Company Information
      • 13.5.2 Terumo Neuro Cerebral Aneurysm Coil Product Portfolios and Specifications
      • 13.5.3 Terumo Neuro Cerebral Aneurysm Coil Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.5.4 Terumo Neuro Main Business Overview
      • 13.5.5 Terumo Neuro Latest Developments
    • 13.6 Penumbra
      • 13.6.1 Penumbra Company Information
      • 13.6.2 Penumbra Cerebral Aneurysm Coil Product Portfolios and Specifications
      • 13.6.3 Penumbra Cerebral Aneurysm Coil Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.6.4 Penumbra Main Business Overview
      • 13.6.5 Penumbra Latest Developments
    • 13.7 Kaneka
      • 13.7.1 Kaneka Company Information
      • 13.7.2 Kaneka Cerebral Aneurysm Coil Product Portfolios and Specifications
      • 13.7.3 Kaneka Cerebral Aneurysm Coil Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.7.4 Kaneka Main Business Overview
      • 13.7.5 Kaneka Latest Developments
    • 13.8 NeuroSafe
      • 13.8.1 NeuroSafe Company Information
      • 13.8.2 NeuroSafe Cerebral Aneurysm Coil Product Portfolios and Specifications
      • 13.8.3 NeuroSafe Cerebral Aneurysm Coil Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.8.4 NeuroSafe Main Business Overview
      • 13.8.5 NeuroSafe Latest Developments
    • 13.9 Zylox Tonbridge
      • 13.9.1 Zylox Tonbridge Company Information
      • 13.9.2 Zylox Tonbridge Cerebral Aneurysm Coil Product Portfolios and Specifications
      • 13.9.3 Zylox Tonbridge Cerebral Aneurysm Coil Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.9.4 Zylox Tonbridge Main Business Overview
      • 13.9.5 Zylox Tonbridge Latest Developments
    • 13.10 Cook Medical
      • 13.10.1 Cook Medical Company Information
      • 13.10.2 Cook Medical Cerebral Aneurysm Coil Product Portfolios and Specifications
      • 13.10.3 Cook Medical Cerebral Aneurysm Coil Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.10.4 Cook Medical Main Business Overview
      • 13.10.5 Cook Medical Latest Developments
    • 13.11 Peijia Medical
      • 13.11.1 Peijia Medical Company Information
      • 13.11.2 Peijia Medical Cerebral Aneurysm Coil Product Portfolios and Specifications
      • 13.11.3 Peijia Medical Cerebral Aneurysm Coil Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.11.4 Peijia Medical Main Business Overview
      • 13.11.5 Peijia Medical Latest Developments
    • 13.12 MicroPort
      • 13.12.1 MicroPort Company Information
      • 13.12.2 MicroPort Cerebral Aneurysm Coil Product Portfolios and Specifications
      • 13.12.3 MicroPort Cerebral Aneurysm Coil Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.12.4 MicroPort Main Business Overview
      • 13.12.5 MicroPort Latest Developments
  • 14 Research Findings and Conclusion

USD 7,320 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.